HONG KONG, Oct 13, 2022 – (ACN Newswire) – Essex Bio-Technology Limited (the Company, together with its subsidiaries, the Group) wishes to announce that Essex Bio-Investment Limited (Essex Bio-Investment), a wholly-owned subsidiary of the Group has on 13 October 2022 successfully secured (i) a patent and know-how licence agreement; and (ii) a patent assignment deed (together as the Agreements) in relation to SkQ1 , an active pharmaceutical ingredient, from Mitotech S.A. (Mitotech), in which Mitotech granted the Group worldwide (excluding Armenia, Belarus, Kazakhstan, Kyrgyzstan, and Russia) (G…
